SJS Investment Consulting’s Integra LifeSciences IART Stock Holding History

SJS Investment Consulting’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.51K	Buy	+251	New	+$3.51K	﹤0.01%	1432
2024 Q4	–	Sell	-3	Closed	-$55	–	1652
2024 Q3	$55	Sell	3 -5	-63%	-$116	﹤0.01%	1610
2024 Q2	$234	Sell	8 -7	-47%	-$208	﹤0.01%	1476
2024 Q1	$532	Sell	15 -1	-6%	-$40	﹤0.01%	1264
2023 Q4	$697	Buy	16 +5	+45%	+$197	﹤0.01%	1109
2023 Q3	$421	Sell	11 -3	-21%	-$126	﹤0.01%	1271
2023 Q2	$576	Sell	14 -6	-30%	-$289	﹤0.01%	1113
2023 Q1	$1.15K	Buy	20 +3	+18%	+$169	﹤0.01%	834
2022 Q4	$953	Buy	17 +9	+113%	+$458	﹤0.01%	954
2022 Q3	$0	Buy	+8	New	+$410	﹤0.01%	1262
2022 Q1	$0	Buy	+2	New	+$132	﹤0.01%	997

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

SJS Investment Consulting's IART Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Integra LifeSciences (IART) in Q2 2026: 251 shares worth $4.51K. The stake represents ﹤0.01% of the portfolio and ranks #1432 among its holdings. This is a return to the name: SJS Investment Consulting previously reported a position in IART as recently as Q3 2024.

SJS Investment Consulting first reported a position in IART in Q1 2022 and has held it in 11 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

SJS Investment Consulting held 251 shares of Integra LifeSciences worth $4.51K as of Q2 2026.
Integra LifeSciences was a new SJS Investment Consulting position in Q2 2026.
Integra LifeSciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1432 holding.
SJS Investment Consulting first reported a position in Integra LifeSciences in Q1 2022 and has held it in 11 quarters since.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.